The anticipated size of the oncology information systems market in 2022 was US$ 2,593.4 million and is estimated to be US$ 2,753.8 million in 2023.
According to the Future Market Insights analysis report, the oncology information systems market is anticipated to expand at a CAGR of 7.8% between 2023 and 2033, totaling around US$ 5,828 million by 2033. Some of the key factors expected to drive oncology information systems market growth include:
The growing demand for oncology information systems (OIS) software to help streamline patient information and data management has increased the demand for various types of oncology information systems (OIS) software. Furthermore, oncology information systems market companies' increased investments in cancer research are expected to drive oncology information systems market growth along with the oncology information systems market future trends.
Key oncology information systems market players are focusing on launching new campaigns and strategic plans to increase product visibility and brand awareness. A hybrid distribution model based on distribution networks and collaborations with oncology information systems market vendors has aided the oncology information systems market growth as well as the oncology information systems market key trends and opportunities.
The oncology information systems market is expected to grow significantly in the coming years, and companies are increasingly investing in the development of innovative and technologically advanced products positively impacting the oncology information systems market adoption trends.
Key players' investments in OIS development might be a massive oncology information systems market opportunity due to a large influx of funding and budgets for the healthcare sector.
AI in oncology is one of the factors driving the oncology information systems market growth. As systems and software are mostly used by pharmaceutical companies and hospitals, they have a high demand for oncology information systems and in turn surging the sales of demand for oncology information systems in end-use facilities.
Key oncology information systems market players are introducing new products in the same category but with limited innovation. Companies may benefit from research and development investments to develop products with more features.
| Attributes | Details |
|---|---|
| Projected Forecast Value (2022) | US$ 2,593.4 million |
| Projected Forecast Value (2023) | US$ 2,753.8 million |
| Projected Forecast Value (2033) | US$ 5,828 million |
| Growth rate | 7.8% CAGR |
| Forecast period | 2023 to 2033 |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global oncology information systems market expanded at a CAGR of 5.1% between 2018 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 7.8% between 2023 and 2033.
The market for oncology information systems is also rising as it has seen significant growth in recent years due to the rise in the prevalence of cancer, the need for better patient outcomes, and the rise in demand for cost-effective cancer care.
Rising Incidence of Cancer Cases
The rising incidence of cancer cases is one of the key factors driving the oncology information systems market growth. A wide range of novel technologies is being developed, with the potential to completely transform the treatment regime.
As a result of the increasing prevalence of cancer, there might be a great demand for oncology information systems to streamline patient information and data management. Consequently, it will eventually drive the oncology information systems market's future trends and the oncology information systems market's key trends and opportunities.
A few other factors are driving the oncology information system market forward, such as the growing need to reduce oncology care costs and the growing adoption of electronic health records (EHR) and other oncology information systems.
Principal Consultant
Lack of Qualified Resources
The lack of qualified resources is a key hindrance to implementing oncology information systems solutions in hospitals. Currently, demand for oncology information systems mainly healthcare IT professionals outnumbers supply in both developing and developed markets, including the United States and Europe. Also, the growing number of healthcare IT initiatives adds to the overall burden.
Traditional Healthcare Delivery Model and Research Systems Influencing the Oncology Information
The healthcare IT industry of the oncology information systems market is divided into several sectors, including medical technology, healthcare, medical devices, and digital health. With the use of modern and advanced technologies, the oncology information systems market is disrupting the traditional healthcare delivery model and research systems influencing the oncology information systems market trends and forecasts.
An integrated healthcare IT environment aids in the identification of gaps in the oncology care continuum while reducing ineffective or unnecessary processing steps. Further, it contributes to the elimination of healthcare redundancy, allowing hospital systems to provide patient-centered care across and between healthcare providers which impacts oncology information systems market opportunities.
Healthcare organizations have reduced operational costs while improving care quality by deploying various healthcare IT solutions and treatment planning solutions. This is fueling demand for oncology information systems among key end-user segments constructively affecting oncology information systems market adoption trends.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The oncology information systems market has been segmented into solutions and professional services based on products and services. The solutions segment accounted for 73.4% of global revenue.
The segment of the oncology information systems market is also expected to grow at a significant rate during the forecast period. Further, this segment is dominating the market due to increasing adoption by healthcare providers for proper radiology imaging management. These solutions aid in the capture of cancer patient-reported outcomes and facilitate direct communication between patients and doctors, resulting in the oncology information systems market growth of this segment.
The development of advanced oncology information systems (OIS) Solutions, which aid in better patient data management and improve cancer treatment, can also be attributed to segment growth. Additionally, the solutions segment of the oncology information systems market is further subdivided into patient information systems and treatment planning systems, with the latter accounting for the largest oncology information systems market share.
Professional services, on the other hand, are becoming widely accepted, as most hospitals and clinics outsource oncology information systems (OIS) services due to a shortage of skilled professionals in hospitals and clinics. These services offer online consultation as well as customized schedules and reports, which help to improve the quality of care.
The medical oncology segment is estimated to account for 61.2% of global revenue. Due to rapid advancements in immunotherapy, hormonal therapy, and targeted therapy for effectively treating various cancers, the medical oncology segment is expected to expand at a significant CAGR over the forecast period.
Several initiatives about cancer research are being undertaken by the leading players, which are positively influencing the oncology information systems market growth as well as the demand for oncology information systems.
North America’s regional oncology information systems market had the significant revenue oncology information systems market at 38.5% with the United States forecasted at a market share of 36%. Moreover, the presence of sophisticated healthcare infrastructure and increased awareness about patient information management in the region are key factors driving oncology information systems market growth along with sales of oncology information systems.
The increasing demand for oncology information systems to track and record cancer patients' treatment outcomes, as well as the growing importance of EMR in making better treatment decisions, are expected to drive regional oncology information systems market growth. Additionally, the increasing demand for treatment schedule management, dose management, and treatment planning is expected to drive up demand for oncology information systems and sales of oncology information systems in this region.
A strong presence of several global players in the region aids the oncology information systems market growth. Countries in Asia like India are forecasted to expand at a CAGR of 7.8% and Japan is forecasted to capture a value share of 4%. These countries are experiencing high demand for oncology information systems and are gradually developing as a result of supportive government policies and increased awareness about the benefits of these systems.
This region may serve as a hot revenue pocket for oncology information systems market players looking to capitalize on the region's potential. As a result, players seeking a large share of the oncology information systems market must develop specific pricing policies as well as marketing strategies tailored to this region to gain a foothold in these leading oncology information systems markets.
Key oncology information systems market companies are primarily focused on incorporating technological innovation with the introduction of web-based oncology solutions and AI-based oncology information systems market solutions. Also, the goal of improving the treatment regime of these companies is expected to positively impact the oncology information systems market growth in the forthcoming years.
The oncology information systems market's key players account for a sizeable portion of the oncology information systems market share and are widely recognized. Moreover, small-to-midsized players are also present in the oncology information systems market. They provide a limited selection of oncology information systems and primarily cater to sales of oncology information systems to local clients.
Since most of these well-known companies have extensive global distribution networks to reach their sizable customer bases, their influence on the oncology information systems market is quite significant.
The leading players in the oncology information systems market are concentrating on strategic initiatives like product launches, acquisitions, collaborations, participation in events, and expansions to boost revenue oncology information systems market growth and solidify their positions in the oncology information systems market,
Recent Developments
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 7.8% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
North America and Europe are projected to emerge as lucrative markets for oncology information systems.
The growth potential of the oncology information systems market is 7.8% through 2033.
The high cost of adoption and lack of awareness about oncology information systems are likely to limit market growth.
North America is likely to generate 35% revenue in 2023.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Solutions
5.3.1.1. Patient Information Systems
5.3.1.2. Treatment Planning Systems
5.3.2. Professional Services
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Medical Oncology
6.3.2. Radiation Oncology
6.3.3. Surgical Oncology
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Product
8.2.3. By Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product
8.3.3. By Application
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product
9.2.3. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Product
10.2.3. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Product
11.2.3. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Product
12.2.3. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product
13.2.3. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product
14.2.3. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Application
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Product
15.1.2.2. By Application
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Product
15.2.2.2. By Application
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Product
15.3.2.2. By Application
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Product
15.4.2.2. By Application
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Product
15.5.2.2. By Application
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Product
15.6.2.2. By Application
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Product
15.7.2.2. By Application
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Product
15.8.2.2. By Application
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Product
15.9.2.2. By Application
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Product
15.10.2.2. By Application
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Product
15.11.2.2. By Application
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Product
15.12.2.2. By Application
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Product
15.13.2.2. By Application
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Product
15.14.2.2. By Application
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Product
15.15.2.2. By Application
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Product
15.16.2.2. By Application
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Product
15.17.2.2. By Application
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Product
15.18.2.2. By Application
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Product
15.19.2.2. By Application
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Product
15.20.2.2. By Application
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Product
15.21.2.2. By Application
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Product
15.22.2.2. By Application
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Product
15.23.2.2. By Application
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product
16.3.3. By Application
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Elekta AB
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Accuray Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Varian Medical Systems
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. RaySearch Laboratories
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Cerner Corp.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. BrainLab
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Philips Healthcare
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Prowess, Inc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. DOSIsoft S.A.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. ViewRay Inc.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. MIM Software
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.12. Flatiron
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Oncology Information Systems Market
